ALEXANDRIA, Va., July 30 -- United States Patent no. 12,371,405, issued on July 29, was assigned to SHANGHAI UNIVERSITY OF MEDICINE AND HEALTH SCIENCES (Shanghai).
"Isoindol-sulfilimine compound and use as a sigma-2 receptor inhibitor thereof" was invented by Xiuhong Lu (Shanghai), Gang Huang (Shanghai), Anyang Sun (Shanghai), Yongsheng Zhang (Shanghai), Jincheng Wang (Shanghai) and Jinjing He (Shanghai).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to an isoindol-sulfilimine compound and its preparation and its use as a sigma-2 receptor inhibitor. Compared with the prior art, the isoindol-sulfilimine compound prepared by the present invention can effectively inhibit the sigma-2...